SummerHaven Investment Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

SummerHaven Investment Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-134,167	Closed	-$220K	–	285
2022 Q2	$220K	Hold	134,167	–	–	0.15%	186
2022 Q1	$394K	Buy	134,167 +6,089	+5%	+$21.3K	0.22%	191
2021 Q4	$612K	Hold	128,078	–	–	0.33%	191
2021 Q3	$970K	Buy	+128,078	New	+$820K	0.57%	30

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SummerHaven Investment Management's SURF Position: Q3 2022 in Review

SummerHaven Investment Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2022, closing a stake of 134,167 shares — an estimated $220K sold.

SummerHaven Investment Management first reported a position in SURF in Q3 2021 and held it in 4 quarters. The position peaked at $970K in Q3 2021. 79 funds tracked by Wall St. Rank hold SURF as of Q3 2022.

SummerHaven Investment Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
SummerHaven Investment Management sold 134,167 Surface Oncology, Inc. Common Stock shares in Q3 2022, an estimated $220K.
SummerHaven Investment Management first reported a position in Surface Oncology, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
SummerHaven Investment Management's Surface Oncology, Inc. Common Stock position peaked at $970K in Q3 2021.
79 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2022.

Based on SummerHaven Investment Management's 13F filing for Q3 2022, filed 20 Oct 2022.